WallStreetZenWallStreetZen

NYSE: MATV
Mativ Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their MATV stock forecasts and price targets.

Forecast return on equity

Is MATV forecast to generate an efficient return?

Company
N/A
Industry
39.62%
Market
180.26%

Forecast return on assets

Is MATV forecast to generate an efficient return on assets?

Company
N/A
Industry
11.37%

MATV earnings per share forecast

What is MATV's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.97
Avg 2 year Forecast
$1.29

MATV revenue forecast

What is MATV's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$2.0B+2.97%
Avg 2 year Forecast
$2.1B+7.3%
Avg 3 year Forecast
$2.1B+7.5%
MATV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MATV revenue growth forecast

How is MATV forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
2.71%
Industry
4.77%
Market
13.48%
MATV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MATV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MATV vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
MATV$8.66N/AN/A
GEVO$2.35$3.00+27.66%Buy
ALTO$4.71N/AN/A
KRO$5.48$5.00-8.76%Strong Sell
OEC$4.72$5.58+18.28%Sell
View Top Specialty Chemical Stocks

Mativ Holdings Stock Forecast FAQ

What is MATV's earnings growth forecast for 2026-2027?

(NYSE: MATV) Mativ Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 8.25%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.23%.

Mativ Holdings's earnings in 2026 is -$337,400,000.On average, 4 Wall Street analysts forecast MATV's earnings for 2026 to be $53,264,873, with the lowest MATV earnings forecast at $45,549,368, and the highest MATV earnings forecast at $60,860,080.

In 2027, MATV is forecast to generate $70,276,168 in earnings, with the lowest earnings forecast at $66,984,365 and the highest earnings forecast at $72,917,266.

If you're new to stock investing, here's how to buy Mativ Holdings stock.

What is MATV's revenue growth forecast for 2026-2028?

(NYSE: MATV) Mativ Holdings's forecast annual revenue growth rate of 2.71% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.

Mativ Holdings's revenue in 2026 is $1,987,000,000.On average, 4 Wall Street analysts forecast MATV's revenue for 2026 to be $111,877,559,244, with the lowest MATV revenue forecast at $106,956,258,984, and the highest MATV revenue forecast at $115,705,237,224. On average, 4 Wall Street analysts forecast MATV's revenue for 2027 to be $116,580,135,048, with the lowest MATV revenue forecast at $108,760,735,746, and the highest MATV revenue forecast at $123,469,955,412.

In 2028, MATV is forecast to generate $116,798,859,504 in revenue, with the lowest revenue forecast at $112,205,645,928 and the highest revenue forecast at $120,243,769,686.

What is MATV's forecast return on assets (ROA) for 2026-2029?

(NYSE: MATV) forecast ROA is N/A, which is lower than the forecast US Specialty Chemicals industry average of 11.37%.

What is MATV's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: MATV) Mativ Holdings's current Earnings Per Share (EPS) is -$6.19. On average, analysts forecast that MATV's EPS will be $0.97 for 2026, with the lowest EPS forecast at $0.83, and the highest EPS forecast at $1.11. In 2027, MATV's EPS is forecast to hit $1.29 (min: $1.23, max: $1.33).

What is MATV's forecast return on equity (ROE) for 2026-2029?

(NYSE: MATV) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.